Cosmos Health (COSM) Common Equity (2011 - 2026)

Cosmos Health has disclosed Common Equity across 16 years of filings, most recently posting $19.8 million for Q1 2026.

• Quarterly Common Equity fell 23.6% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.8 million (down 23.6% YoY) and the FY2025 annual result came in at $18.4 million, down 24.9% from the prior year.
• Common Equity climbed to $19.8 million in Q1 2026, from $18.4 million in the prior quarter.
• Over five years, Common Equity peaked at $44.2 million in Q3 2023 and troughed at $3.4 million in Q3 2022.
• A 5-year average of $27.1 million and a median of $26.2 million in 2025 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity jumped 1234.05% — and 2025, when it tumbled 33.86%.
• Tracing COSM's Common Equity over 5 years: stood at $39.3 million in 2022, then retreated by 8.25% to $36.0 million in 2023, then slumped by 31.93% to $24.5 million in 2024, then fell by 24.9% to $18.4 million in 2025, then advanced by 7.61% to $19.8 million in 2026.
• Business Quant data shows COSM's Common Equity at $19.8 million in Q1 2026, $18.4 million in Q4 2025, and $23.1 million in Q3 2025.